Ashok Chander says he had a simple reason for moving his startup, Cellanyx Diagnostics, from New York City to Boston.
“Bluntly, it’s because of the talent and funding environment in the Boston area and Cambridge,” said Chander, CEO of the cancer-diagnostics company, which has offices in Boston and lab space in Beverly, MA, just north of the city. “It’s such a rich and very diversified life-sciences community here. My (angel) investors are based in Cambridge, and our labs are in an incubator space in Beverly, only a 50-minute drive away. It’s very convenient.”
In recent years, a lot of other life-science companies, whether small startups like Cellanyx or Switzerland’s giant Novartis, have been flocking to the Boston-Cambridge market, leasing out small lab spaces or spending hundreds of millions of dollars on gleaming new research facilities and headquarters. → Keep Reading
. Add comment.